Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the national cardiovascular data registry during the years 2006 to 2008

American Journal of Cardiology

Volumn 113, Issue 12, 2014, Pages 2052-2056

  Schneider, Preston M ^a   Pellegrini, Cara N ^b,c   Wang, Yongfei ^d   Fein, Adam S ^e   Reynolds, Matthew R ^e   Curtis, Jeptha P ^d   Masoudi, Frederick A ^a,f,g   Varosy, Paul D ^a,f,h  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f Colorado Cardiovascular Outcomes Research ^*  (United States)

^g DENVER HEALTH MEDICAL CENTER   (United States)

^h UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; DRUG CONTRAINDICATION; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REGISTER; SUDDEN DEATH;

ADRENERGIC BETA-ANTAGONISTS; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC RESYNCHRONIZATION THERAPY; COMBINED MODALITY THERAPY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84901595420     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.03.049     Document Type: Article

References (27)

1. CIBIS-II Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
2. M. Packer, A.J.S. Coats, M.B. Fowler, H.A. Katus, H. Krum, P. Mohacsi, J.L. Rouleau, M. Tendera, A. Castaigne, E.B. Roecker, M.K. Schultz, C. Staiger, E.L. Curtin, and D.L. DeMets Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
3. M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, E.M. Gilbert, and N.H. Shusterman The effect of carvedilol on morbidity and mortality in patients with chronic heart failure N Engl J Med 334 1996 1349 1355
4. A. Hjalmarson, S. Goldstein, B. Fagerberg, H. Wedel, F. Waagstein, J. Kjekshus, J. Wikstrand, D. El Allaf, J. Vitovec, J. Aldershvile, M. Halinen, R. Dietz, K.-L. Neuhaus, A. Janosi, G. Thorgeirsson, P.H. Dunselman, L. Gullestad, J. Kuch, J. Herlitz, P. Rickenbacher, S. Ball, S. Gottlieb, P. Deedwania for the MERIT-HF Study Group Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) JAMA 283 2000 1295 1302
5. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
6. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure N Engl J Med 316 1987 1429 1435
7. J.N. Cohn, G. Johnson, S. Ziesche, F. Cobb, G. Francis, F. Tristani, R. Smith, W.B. Dunkman, H. Loeb, M. Wong, G. Bhat, S. Goldman, R.D. Fletcher, J. Doherty, C.V. Hughes, P. Carson, G. Cintron, R. Shabetai, and C. Haakenson A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure N Engl J Med 325 1991 303 310
8. M. Wong, L. Staszewsky, R. Latini, S. Barlera, A. Volpi, Y.-T. Chiang, R.L. Benza, S.O. Gottlieb, T.D. Kleemann, F. Rosconi, P.M. Vandervoort, and J.N. Cohn Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study J Am Coll Cardiol 40 2002 970 975
9. J.J. McMurray, J. Östergren, K. Swedberg, C.B. Granger, P. Held, E.L. Michelson, B. Olofsson, S. Yusuf, and M.A. Pfeffer Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial The Lancet 362 2003 767 771
10. J.N. Cohn, and G. Tognoni A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 2001 1667 1675
11. S. Hunt, W. Abraham, F. Chin, A. Feldman, F. Francis, F. Ganiats, M. Jessup, F. Konstam, D. Mancini, K. Michl, and V. Fuster ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 46 2005 e1 e82
12. Writing Committee Members A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, N.A.M. Estes, R.A. Freedman, L.S. Gettes, A.M. Gillinov, G. Gregoratos, S.C. Hammill, D.L. Hayes, M.A. Hlatky, L.K. Newby, R.L. Page, M.H. Schoenfeld, M.J. Silka, L.W. Stevenson, and M.O. Sweeney ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350 408
13. M. Jessup, W.T. Abraham, D.E. Casey, A.M. Feldman, G.S. Francis, T.G. Ganiats, M.A. Konstam, D.M. Mancini, P.S. Rahko, M.A. Silver, L.W. Stevenson, and C.W. Yancy 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 1343 1382
14. A.S. Fein, Y. Wang, J.P. Curtis, F.A. Masoudi, P.D. Varosy, and M.R. Reynolds Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry J Am Coll Cardiol 56 2010 766 773
15. W.T. Abraham, W.G. Fisher, A.L. Smith, D.B. Delurgio, A.R. Leon, E. Loh, D.Z. Kocovic, M. Packer, A.L. Clavell, D.L. Hayes, M. Ellestad, R.J. Trupp, J. Underwood, F. Pickering, C. Truex, P. McAtee, and J. Messenger Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
16. I.S. Anand, P. Carson, E. Galle, R. Song, J. Boehmer, J.K. Ghali, B. Jaski, J. Lindenfeld, C. O'Connor, J.S. Steinberg, J. Leigh, P. Yong, M.R. Kosorok, A.M. Feldman, D. DeMets, and M.R. Bristow Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial Circulation 119 2009 969 977
17. M.R. Bristow, L.A. Saxon, J. Boehmer, S. Krueger, D.A. Kass, T. De Marco, P. Carson, L. DiCarlo, D. DeMets, B.G. White, D.W. DeVries, and A.M. Feldman Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
18. J.G.F. Cleland, J.-C. Daubert, E. Erdmann, N. Freemantle, D. Gras, L. Kappenberger, and L. Tavazzi The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
19. A.J. Moss, W.J. Hall, D.S. Cannom, H. Klein, M.W. Brown, J.P. Daubert, N.A.M. Estes, E. Foster, H. Greenberg, S.L. Higgins, M.A. Pfeffer, S.D. Solomon, D. Wilber, and W. Zareba Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
20. C. Linde, W.T. Abraham, M.R. Gold, M. St John Sutton, S. Ghio, and C. Daubert Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms J Am Coll Cardiol 52 2008 1834 1843
21. A. Auricchio, C. Stellbrink, S. Sack, M. Block, J. Vogt, P. Bakker, C. Huth, F. Schondube, U. Wolfhard, D. Bocker, O. Krahnefeld, and H. Kirkels Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay J Am Coll Cardiol 39 2002 2026 2033
22. M.G. St John Sutton, T. Plappert, W.T. Abraham, A.L. Smith, D.B. DeLurgio, A.R. Leon, E. Loh, D.Z. Kocovic, W.G. Fisher, M. Ellestad, J. Messenger, K. Kruger, K.E. Hilpisch, and M.R.S. Hill Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure Circulation 107 2003 1985 1990
23. J. Lindenfeld, A.M. Feldman, L. Saxon, J. Boehmer, P. Carson, J.K. Ghali, I. Anand, S. Singh, J.S. Steinberg, B. Jaski, T. DeMarco, D. Mann, P. Yong, E. Galle, F. Ecklund, and M. Bristow Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure Circulation 115 2007 204 212
24. E.D. Peterson, M.T. Roe, J. Mulgund, E.R. DeLong, B.L. Lytle, R.G. Brindis, S.C. Smith, C.V. Pollack, L.K. Newby, R.A. Harrington, W.B. Gibler, and E.M. Ohman Association between hospital process performance and outcomes among patients with acute coronary syndromes JAMA 295 2006 1912 1920
25. G.C. Fonarow, W.T. Abraham, N.M. Albert, W.G. Stough, M. Gheorghiade, B.H. Greenberg, C.M. O'Connor, K. Pieper, J.L. Sun, C. Yancy, and J.B. Young Association between performance measures and clinical outcomes for patients hospitalized with heart failure JAMA 297 2007 61 70
26. The Joint Commission. Annual report - improving America's hospitals. Joint Commission. Available at: http://www.jointcommission.org/annualreport. aspx. Accessed December 9, 2013.
27. Messenger JC, Ho KKL, Young CH, Slattery LE, Draoui JC, Curtis JP, Dehmer GJ, Grover FL, Mirro MJ, Reynolds MR, Rokos IC, Spertus JA, Wang TY, Winston SA, Rumsfeld JS, Masoudi FA. The National Cardiovascular Data Registry (NCDR) data quality brief: the NCDR Data Quality Program in 2012. J Am Coll Cardiol. Available at: http://www.sciencedirect.com/science/article/pii/ S073510971202815X.